SEC Filing Update: #BBIO BridgeBio Pharma, Inc. : $80.00

Sector: Healthcare | YTD: 🔼+ 2.25% The SEC disclosed Today (17-AUG-2026) that KKR GENETIC DISORDER L.P. has DECREASED #BBIO Shares by -30.38% 🔴 * Previous Holdings: 13.26M Shares * Current Holdings: 9.23M Shares * Decrease -4.03M * Decreased (%)-30.38% * Ownership: 4.2% https://www.thinksabio.com/reports/isr/BBIO 📌 Institutional activity in the last 30 days for #BBIO: • FARALLON CAPITAL MANAGEMENT LLC – Increased holdings by 1,377,600 shares (03-AUG-2026) KKR Genetic Disorder L.P. reduced its stake in BBIO from 13,260,971 shares to 9,232,739 shares, a decrease of 4,028,232 shares, while maintaining a 4.2% ownership position.